Skip to main content
. 2024 Aug 27;16(9):1128. doi: 10.3390/pharmaceutics16091128

Figure 9.

Figure 9

In-vitro cytotoxicity study of different SDL and DSDL formulations to calculate the IC-50 value on (a) SK-BR-3 and (b) MDA-MB-231 breast cancers cells. All the data represented as mean ± SD, (n = 3). p < 0.05, 0.01, and 0.001 are denoted by *, **, and ***, respectively. * Represents that the data are significant whereas ** and *** indicate highly significant data.